ArticleCell reports. Medicine2025

Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.